|
GATAD2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.395800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.052600E-01 |
| Normal-vs-Stage2 |
6.197000E-01 |
| Normal-vs-Stage3 |
1.843570E-01 |
| Normal-vs-Stage4 |
6.196600E-01 |
| Stage1-vs-Stage2 |
5.590000E-01 |
| Stage1-vs-Stage3 |
8.332600E-01 |
| Stage1-vs-Stage4 |
5.003000E-01 |
| Stage2-vs-Stage3 |
5.055000E-01 |
| Stage2-vs-Stage4 |
9.624600E-01 |
| Stage3-vs-Stage4 |
4.407400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.435600E-01 |
| Normal-vs-AfricanAmerican |
2.950200E-01 |
| Normal-vs-Asian |
3.501400E-01 |
| Caucasian-vs-AfricanAmerican |
5.354100E-02 |
| Caucasian-vs-Asian |
9.299000E-01 |
| AfricanAmerican-vs-Asian |
8.346400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.329800E-01 |
| Normal-vs-Female |
2.310200E-01 |
| Male-vs-Female |
8.240800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.828180E-01 |
| Normal-vs-Age(41-60Yrs) |
3.791800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.636600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.221440E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.405200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.815000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.480600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.161600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.521200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.719800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.669800E-02 |
| Classical-VS-Follicular |
1.383800E-04 |
| Classical-VS-Other |
1.305210E-01 |
| Classical-VS-Normal |
9.900200E-01 |
| Tall-VS-Follicular |
7.974400E-01 |
| Tall-VS-Other |
7.236800E-01 |
| Tall-VS-Normal |
4.725900E-02 |
| Follicular-VS-Other |
8.411200E-01 |
| Follicular-VS-Normal |
8.421300E-03 |
| Other-VS-Normal |
1.232950E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.339750E-01 |
| Normal-vs-N1 |
2.787600E-02 |
| N0-vs-N1 |
3.706000E-01 |
|
|
